IMMUNIVATION

Serial Number 88319626
602

Registration Progress

Application Filed
Feb 28, 2019
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

IMMUNIVATION

Basic Information

Serial Number
88319626
Filing Date
February 28, 2019
Abandonment Date
May 28, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 1, 2020
Classes
005 042

Rights Holder

Nektar Therapeutics

03
Address
455 Mission Bay Boulevard South
San Francisco, CA 94158

Ownership History

Nektar Therapeutics

Original Applicant
03
San Francisco, CA

Legal Representation

Attorney
Jennifer D. Arkowitz

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Jul 1, 2020 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 1, 2020 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Nov 27, 2019 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 27, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 27, 2019 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 25, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 25, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 24, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 19, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 19, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 19, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 9, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 19, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, pharmaceutical preparations for the treatment and/or prophylaxis of diseases or medical conditions, namely, pharmaceutical preparations for the treatment of cancers; pharmaceuticals, namely, an anti-cancer agent
Class 042
Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields

Classification

International Classes
005 042